Modulation of tumor induction and progression of oncogenic K-ras-positive tumors in the presence of TGF-β1 haploinsufficiency

Oncogenic K-ras is one of the most common genetic alterations in human lung adenocarcinomas. In addition, inactivation of clusters of tumor suppressor genes is required to bring about classical characteristics of cancer including angiogenesis as a prelude to invasion and metastasis. Transforming gro...

Full description

Saved in:
Bibliographic Details
Published inCarcinogenesis (New York) Vol. 28; no. 12; pp. 2589 - 2596
Main Authors Pandey, Jyotsna, Umphress, Sarah M., Kang, Yang, Angdisen, Jerry, Naumova, Alena, Mercer, Kim L., Jacks, Tyler, Jakowlew, Sonia B.
Format Journal Article
LanguageEnglish
Published Oxford Oxford University Press 01.12.2007
Subjects
Online AccessGet full text
ISSN0143-3334
1460-2180
DOI10.1093/carcin/bgm136

Cover

Abstract Oncogenic K-ras is one of the most common genetic alterations in human lung adenocarcinomas. In addition, inactivation of clusters of tumor suppressor genes is required to bring about classical characteristics of cancer including angiogenesis as a prelude to invasion and metastasis. Transforming growth factor-β (TGF-β) 1 is a tumor suppressor gene that is implicated in lung cancer progression. Although in vitro studies have shown that TGF-β1 and Ras pathways cooperate during tumorigenesis, the biology of interaction of TGF-β1 and Ras has not been studied in in vivo tumorigenesis. We hypothesized that inactivation of TGF-β1 in addition to oncogeneic activation of K-ras would lead to early initiation and faster progression to lung adenocarcinoma and invasion and metastasis. Heterozygous (HT) TGF-β1 mice were mated with latent activatable (LA) mutated K-ras mice to generate TGF-β1+/+, K-ras LA (wild-type (WT)/LA) and TGF-β1+/−, K-ras LA (HT/LA) mice. Both HT/LA and WT/LA mice developed spontaneous lung tumors, but HT/LA mice progressed to adenocarcinomas significantly earlier compared with WT/LA mice. In addition, WT/LA adenocarcinomas had significantly higher angiogenic activity compared with HT/LA adenocarcinomas. Thus, while oncogenic K-ras mutation and insensitivity to the growth regulatory effects of TGF-β1 is essential for initiation and progression of mouse lung tumors to adenocarcinoma, a full gene dosage of TGF-β1 is required for tumor-induced angiogenesis and invasive potential. This study identifies a number of genes not previously associated with lung cancer that are involved in tumor induction and progression. In addition, we provide evidence that progression to invasive angiogenic lesions requires TGF-β1 responsiveness in addition to Ras mutation.
AbstractList Oncogenic K-ras is one of the most common genetic alterations in human lung adenocarcinomas. In addition, inactivation of clusters of tumor suppressor genes is required to bring about classical characteristics of cancer including angiogenesis as a prelude to invasion and metastasis. Transforming growth factor-β (TGF-β) 1 is a tumor suppressor gene that is implicated in lung cancer progression. Although in vitro studies have shown that TGF-β1 and Ras pathways cooperate during tumorigenesis, the biology of interaction of TGF-β1 and Ras has not been studied in in vivo tumorigenesis. We hypothesized that inactivation of TGF-β1 in addition to oncogeneic activation of K-ras would lead to early initiation and faster progression to lung adenocarcinoma and invasion and metastasis. Heterozygous (HT) TGF-β1 mice were mated with latent activatable (LA) mutated K-ras mice to generate TGF-β1+/+, K-ras LA (wild-type (WT)/LA) and TGF-β1+/−, K-ras LA (HT/LA) mice. Both HT/LA and WT/LA mice developed spontaneous lung tumors, but HT/LA mice progressed to adenocarcinomas significantly earlier compared with WT/LA mice. In addition, WT/LA adenocarcinomas had significantly higher angiogenic activity compared with HT/LA adenocarcinomas. Thus, while oncogenic K-ras mutation and insensitivity to the growth regulatory effects of TGF-β1 is essential for initiation and progression of mouse lung tumors to adenocarcinoma, a full gene dosage of TGF-β1 is required for tumor-induced angiogenesis and invasive potential. This study identifies a number of genes not previously associated with lung cancer that are involved in tumor induction and progression. In addition, we provide evidence that progression to invasive angiogenic lesions requires TGF-β1 responsiveness in addition to Ras mutation.
Oncogenic K-ras is one of the most common genetic alterations in human lung adenocarcinomas. In addition, inactivation of clusters of tumor suppressor genes is required to bring about classical characteristics of cancer including angiogenesis as a prelude to invasion and metastasis. Transforming growth factor-β (TGF-β) 1 is a tumor suppressor gene that is implicated in lung cancer progression. Although in vitro studies have shown that TGF-β1 and Ras pathways cooperate during tumorigenesis, the biology of interaction of TGF-β1 and Ras has not been studied in in vivo tumorigenesis. We hypothesized that inactivation of TGF-β1 in addition to oncogeneic activation of K-ras would lead to early initiation and faster progression to lung adenocarcinoma and invasion and metastasis. Heterozygous (HT) TGF-β1 mice were mated with latent activatable (LA) mutated K-ras mice to generate TGF-β1+/+ , K-ras LA (wild-type (WT)/LA) and TGF-β1+/− , K-ras LA (HT/LA) mice. Both HT/LA and WT/LA mice developed spontaneous lung tumors, but HT/LA mice progressed to adenocarcinomas significantly earlier compared with WT/LA mice. In addition, WT/LA adenocarcinomas had significantly higher angiogenic activity compared with HT/LA adenocarcinomas. Thus, while oncogenic K-ras mutation and insensitivity to the growth regulatory effects of TGF-β1 is essential for initiation and progression of mouse lung tumors to adenocarcinoma, a full gene dosage of TGF-β1 is required for tumor-induced angiogenesis and invasive potential. This study identifies a number of genes not previously associated with lung cancer that are involved in tumor induction and progression. In addition, we provide evidence that progression to invasive angiogenic lesions requires TGF-β1 responsiveness in addition to Ras mutation.
Author Kang, Yang
Jacks, Tyler
Angdisen, Jerry
Naumova, Alena
Mercer, Kim L.
Jakowlew, Sonia B.
Pandey, Jyotsna
Umphress, Sarah M.
Author_xml – sequence: 1
  givenname: Jyotsna
  surname: Pandey
  fullname: Pandey, Jyotsna
  organization: Cell and Cancer Biology Branch, National Cancer Institute, 9610 Medical Center Drive, Suite 300, Rockville, MD 20850, USA
– sequence: 2
  givenname: Sarah M.
  surname: Umphress
  fullname: Umphress, Sarah M.
  organization: Cell and Cancer Biology Branch, National Cancer Institute, 9610 Medical Center Drive, Suite 300, Rockville, MD 20850, USA
– sequence: 3
  givenname: Yang
  surname: Kang
  fullname: Kang, Yang
  organization: Cell and Cancer Biology Branch, National Cancer Institute, 9610 Medical Center Drive, Suite 300, Rockville, MD 20850, USA
– sequence: 4
  givenname: Jerry
  surname: Angdisen
  fullname: Angdisen, Jerry
  organization: Cell and Cancer Biology Branch, National Cancer Institute, 9610 Medical Center Drive, Suite 300, Rockville, MD 20850, USA
– sequence: 5
  givenname: Alena
  surname: Naumova
  fullname: Naumova, Alena
  organization: Cell and Cancer Biology Branch, National Cancer Institute, 9610 Medical Center Drive, Suite 300, Rockville, MD 20850, USA
– sequence: 6
  givenname: Kim L.
  surname: Mercer
  fullname: Mercer, Kim L.
  organization: Center for Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139, USA
– sequence: 7
  givenname: Tyler
  surname: Jacks
  fullname: Jacks, Tyler
  organization: Center for Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139, USA
– sequence: 8
  givenname: Sonia B.
  surname: Jakowlew
  fullname: Jakowlew, Sonia B.
  email: jakowles@mail.nih.gov
  organization: E-mail: jakowles@mail.nih.gov
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=19914562$$DView record in Pascal Francis
BookMark eNpFkMFOAjEURRuDiYgu3c_GxE2lb0oLXRoiYMCYEEyMm6Z0OlCFdtLOGNn4UX6I3-TAEF295N5z3uKeo5bzziB0BeQWiKBdrYK2rrtcbYHyE9SGHic4hQFpoTaBHsWU0t4ZOo_xjRDglIk2-nr0WbVRpfUu8XlSVlsfEuuySh8i5bKkCH4VTIxHxDvtV8ZZnUxxUBEXPtrSfpjGjbWclGtTWyYap81eWYxH-OcbkrUqNt66WOW51bZudxfoNFebaC6Pt4OeR_eL4QTPnsYPw7sZttCHEoMeZJoYYCQjKRGw5JRoasQAhEozA7nRjGrGORWZGTBgIk_TPiNKUcI5T2kHXTd_CxW12uRBOW2jLILdqrCTIAT02IG7aThfFf8tkft9ZbOvbPatUdygNpbm8w9W4V3yPu0zOXl5lXMxnU9nMJRj-gujpIL9
CODEN CRNGDP
ContentType Journal Article
Copyright Published by Oxford University Press 2007. 2007
2008 INIST-CNRS
Copyright_xml – notice: Published by Oxford University Press 2007. 2007
– notice: 2008 INIST-CNRS
DBID BSCLL
IQODW
DOI 10.1093/carcin/bgm136
DatabaseName Istex
Pascal-Francis
DatabaseTitleList

DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1460-2180
EndPage 2596
ExternalDocumentID 19914562
10.1093/carcin/bgm136
ark_67375_HXZ_R9KRKL1C_G
GroupedDBID ---
-E4
.2P
.I3
.ZR
0R~
18M
1TH
29B
2WC
4.4
482
48X
53G
5GY
5RE
5VS
5WA
5WD
6J9
70D
A8Z
AABZA
AACZT
AAIMJ
AAJKP
AAJQQ
AAMDB
AAMVS
AAOGV
AAPNW
AAPQZ
AAPXW
AARHZ
AAUAY
AAUQX
AAVAP
AAVLN
ABDFA
ABEJV
ABEUO
ABGNP
ABIXL
ABJNI
ABKDP
ABLJU
ABMNT
ABNHQ
ABNKS
ABPQP
ABPTD
ABQLI
ABVGC
ABWST
ABXVV
ABXZS
ABZBJ
ACGFO
ACGFS
ACNCT
ACPRK
ACUFI
ACUTJ
ACUTO
ADBBV
ADEYI
ADEZT
ADFTL
ADGKP
ADGZP
ADHKW
ADHZD
ADIPN
ADNBA
ADOCK
ADQBN
ADRTK
ADVEK
ADYVW
ADZTZ
ADZXQ
AEGPL
AEGXH
AEJOX
AEKSI
AELWJ
AEMDU
AENEX
AENZO
AEPUE
AETBJ
AEWNT
AFFNX
AFFZL
AFGWE
AFIYH
AFOFC
AFRAH
AGINJ
AGKEF
AGQPQ
AGQXC
AGSYK
AHMBA
AHMMS
AHXPO
AIAGR
AIJHB
AJBYB
AJEEA
AJNCP
AKHUL
AKWXX
ALMA_UNASSIGNED_HOLDINGS
ALUQC
ALXQX
APIBT
APWMN
ARIXL
ASPBG
ATGXG
AVWKF
AXUDD
AYOIW
AZFZN
BAWUL
BAYMD
BCRHZ
BEYMZ
BHONS
BQDIO
BSCLL
BSWAC
BTRTY
BVRKM
C1A
C45
CAG
CDBKE
COF
CS3
CZ4
DAKXR
DIK
DILTD
DU5
D~K
E3Z
EBD
EBS
EE~
EJD
EMOBN
ESTFP
F5P
F9B
FEDTE
FHSFR
FLUFQ
FOEOM
FOTVD
FQBLK
GAUVT
GJXCC
GX1
H13
H5~
HAR
HVGLF
HW0
HZ~
IH2
IOX
J21
JXSIZ
KAQDR
KBUDW
KOP
KQ8
KSI
KSN
M-Z
N9A
NGC
NLBLG
NOMLY
NOYVH
NTWIH
NU-
NVLIB
O0~
O9-
OAWHX
OBOKY
OCZFY
ODMLO
OJQWA
OJZSN
OK1
OPAEJ
OVD
OWPYF
P2P
PAFKI
PB-
PEELM
PQQKQ
Q1.
Q5Y
R44
RD5
ROL
ROX
ROZ
RUSNO
RW1
RXO
SV3
TEORI
TJX
TLC
TR2
W8F
WOQ
X7H
YAYTL
YKOAZ
YXANX
ZKX
~91
.55
.GJ
3O-
6.Y
AAPGJ
AASNB
AAWDT
ABEFU
ABQTQ
ABSAR
ABSMQ
ACFRR
ACMRT
ACPQN
ACZBC
ADJQC
ADRIX
AEKPW
AFSHK
AFXEN
AFYAG
AGKRT
AGMDO
ANFBD
APJGH
AQDSO
AQKUS
ASAOO
ATDFG
ATTQO
AVNTJ
BZKNY
CXTWN
DFGAJ
EIHJH
ELUNK
FRP
KC5
M49
MBLQV
MBTAY
O~Y
QBD
RHF
RIG
RNI
RZF
RZO
TCN
TMA
X7M
XOL
ZGI
ZKB
ZXP
ABIME
ABPIB
ABZEO
ACVCV
ADMTO
AEHUL
AFFQV
AGORE
AHGBF
AJDVS
IQODW
OBFPC
ID FETCH-LOGICAL-i171t-1c8dc0e150d02091b630c3e9819a2de1fec53c56639de85159f22750aa3066623
ISSN 0143-3334
IngestDate Mon Jul 21 09:13:36 EDT 2025
Wed Aug 28 03:24:21 EDT 2024
Sat Sep 20 11:02:04 EDT 2025
IsPeerReviewed true
IsScholarly true
Issue 12
Keywords K ras Gene
Induction
C-Onc gene
Modulation
Loss of heterozygosity
Tumor progression
Tumor
Transforming growth factor β1
Onc gene
Carcinogenesis
Protooncogene
Language English
License CC BY 4.0
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-i171t-1c8dc0e150d02091b630c3e9819a2de1fec53c56639de85159f22750aa3066623
Notes istex:630F140DB47EEE400D5588481DD57E25FF06EC74
ark:/67375/HXZ-R9KRKL1C-G
PageCount 8
ParticipantIDs pascalfrancis_primary_19914562
oup_primary_10_1093_carcin_bgm136
istex_primary_ark_67375_HXZ_R9KRKL1C_G
PublicationCentury 2000
PublicationDate 2007-12-00
PublicationDateYYYYMMDD 2007-12-01
PublicationDate_xml – month: 12
  year: 2007
  text: 2007-12-00
PublicationDecade 2000
PublicationPlace Oxford
PublicationPlace_xml – name: Oxford
PublicationTitle Carcinogenesis (New York)
PublicationYear 2007
Publisher Oxford University Press
Publisher_xml – name: Oxford University Press
SSID ssj0016359
Score 1.925578
Snippet Oncogenic K-ras is one of the most common genetic alterations in human lung adenocarcinomas. In addition, inactivation of clusters of tumor suppressor genes is...
SourceID pascalfrancis
oup
istex
SourceType Index Database
Publisher
StartPage 2589
SubjectTerms Biological and medical sciences
Carcinogenesis, carcinogens and anticarcinogens
Medical sciences
Tumors
Title Modulation of tumor induction and progression of oncogenic K-ras-positive tumors in the presence of TGF-β1 haploinsufficiency
URI https://api.istex.fr/ark:/67375/HXZ-R9KRKL1C-G/fulltext.pdf
Volume 28
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFLbKkBASQlxFuUxGYrxU3uI4l-YRqm2FUoSmViq8RI7tlAmWVG2KgAd-FD-EX8CP4fjSNB2dNHiJoshO3ZwvORd_5xyEnkU8kTHNJBEeD0kQJJIkfsYJjSJP5iDz2OzgD99G_XHwehJOWq3fDdbSssr2xfeteSX_I1W4BnLVWbL_INn6pnABzkG-cAQJw_FSMh6W0nXfMlv9yzNDLpdL1_7blAAop5bpaoaUhSjhbqeiMyBzviCWsvVF2bmLFelxZnKShAknjI6PyF7vcO-lTzsf-exzqdnrpu6ETtps2rY93Zao0PdXusrJRpufOtzwTgetbZfkb2W1KGqtMDawsi3cTZi6M9yvtYELar_nTs-auMVUby7Z1BI1d2zmVfwiPscFuSAvciPkyQhjLuSp7Gc6iDwCxonX_I773SZe_eZXObRtipyGB48v2qo9bGUtYZ4WnGTTM8q21Ok-pz9rViOff9I0uThM-5MP6UkyOBm8ob30-Aq66sdg2WmT_dWg3uMCUy-xBFv7_1wFWFjEgV3CgV0AuE36jf-6SsG8MeMLeH9z23ilYQ2NbqGbzo3BLywmb6OWKu6ga0NH1LiLfqyhicscG3jhGpoYQIAb0NRDamjiTWjauQuYjAGaeAVNPUVD89dPiv-G5T00Pjoc9frEtfogpzSmFaGiK4WnwDuR4L8kNIuYJ5hKwF7lvlQ0VyJkAlwPlkjV1TZ47uvOBJwz7YD77D7aKcpCPUA4k-BFREmc-ywIeDficS6Yr-IuqHWhQtlGz83jTGe2nEt6kdja6Ck873qYZWuw1MomtbJpo90NaaxHg9-lgwsPL_trj9D19dvxGO1U86V6AvZule0a2PwBku6yTw
linkProvider Flying Publisher
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Modulation+of+tumor+induction+and+progression+of+oncogenic+K-ras-positive+tumors+in+the+presence+of+TGF-%CE%B21+haploinsufficiency&rft.jtitle=Carcinogenesis+%28New+York%29&rft.au=Pandey%2C+Jyotsna&rft.au=Umphress%2C+Sarah+M.&rft.au=Kang%2C+Yang&rft.au=Angdisen%2C+Jerry&rft.date=2007-12-01&rft.pub=Oxford+University+Press&rft.issn=0143-3334&rft.eissn=1460-2180&rft.volume=28&rft.issue=12&rft.spage=2589&rft.epage=2596&rft_id=info:doi/10.1093%2Fcarcin%2Fbgm136&rft.externalDBID=n%2Fa&rft.externalDocID=ark_67375_HXZ_R9KRKL1C_G
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0143-3334&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0143-3334&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0143-3334&client=summon